| 1) |
厚生省免疫・アレルギー研究班. 喘息予防・管理ガイドライン1998改訂版．協和企画；2000. |
| 2) |
Reed CE, Offord KP, Nelson HS, et al. Aerosol beclomethasone dipropinate spray compared with theophylline as primary treatment for chronic mild-to-moderate asthma. J Allergy Clin Immunol 1998; 101:14-23. |
| 3) |
Malmstrom K, Rodriguez-Gomez G, Guerra J, et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Ann Intern Med 1999 ; 130:487-95. |
| 4) |
Faurschou P, Bing J, Edman G, et al. Comparison between sodium cromoglycate (MDI:metered-dose inhaler) and beclomethasone dipropinate (MDI) in treatment of adult patients with mild to moderate bronchial asthma. A double-blind, double-dummy, randomized, parallel-group study. Allergy 1994; 49:659-63. |
| 5) |
Overbeek SE, Kerstjens HA, Bogaard JM, et al. Is delayed introduction of inhaled corticosteroids harmful in patients with obstructive airways disease (asthma and COPD) ? Chest 1996; 110:35-41. |
| 6) |
Olivieri D, Chetta A, Del Donno M, et al. Effect of short term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma : a placebo-controlled study. Am J Respir Crit Care Med 1997 ; 155: 1864-71. |
| 7) |
Suissa S, Ernst P, Benayoun S, et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000;343:332-6, |
| 8) |
厚生省喘息ガイドライン作成研究班.喘息ガイドライン作成に関する研究報告書: 2001. |
| 9) |
Hoshino M, Nakamura Y. The effect of azelastine on the infiltration of inflammatory cells into the bronchial mucosa and clinical changes in patients with bronchial asthma. Int Arch Allergy Immunol 1997;114:285-92, |
| 10) |
Tamaoki J, Kondo M, Sakai N, et al. Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. Am J Respir Crit Care Med 1997;155:1235-40. |
| 11) |
Sano Y, Makino S, Miyamoto T. Anti-inflammatory effect of supulatast tosilate on mild asthma. Chest 1997;112:862-3. |
| 12) |
Tamaoki J, Kondo M, Sasaki N, et al. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma : a double-blind randomised study. Lancet 2000;
356:273-8. |
| 13) |
Bjermer L, Bisgaard H, Bosquet J, et al. Montelukast or salmeterol combined with an inhaled steroid in adult asthma:design and rationale of a randomized, double-blind comparative study. Respir Med 2000;94: 612-21. |
| 14) |
中川武正.抗アレルギー薬:その到達点と今後の展望．治療学2001;35:471-4. |
| 15) |
石川哮,大山勝,奥田稔ほか.鼻アレルギー診療ガイドライン:通年性鼻炎と花粉症（1999年改訂版）. ライフサイエンスメディカ； 1999.nale of a randomized, double-blind comparative study. Respir Med 2000;94: 612-21. |
| 16) |
吉田博一,馬場廣太郎.抗アレルギー薬による花粉症初期療法の実際. アレルギーの臨床2001;21:194-8. |
| 17) |
湯田厚司,坂倉康夫.花粉症の治療指針. Prog Med 1998;18:2818. |
| 18) |
Wilson AW, Orr LC, Sims EJ, et al. Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma. Am J Respir Crit Care Med 2000;162:1297-301. |
| 19) |
van Cauwenverge P, et al. Consensus statement on the treatment of allergic rhinitis. Allegy 2000;55:116-34. |
| 20) |
Weiner JM, Abramsom MJ, Pufy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 1998;317:1624-9. |
| 21) |
中川武正.喘息治療の将来展望. In:中川武正編. 喘息治療の新たな展開: Focus on Zafirlukast. メディカルレビュー社; 2001.148-154. |
| 22) |
Milgrom H, Fick RB, Su JQ, et al. Treatment of allergic asthma with monoclonal anti-IgE antibody. N Engl J Med 1999;341: 1966-73. |
| 23) |
Cuss FM. Allergy and respiratory drug discovery and development in Schering-Plough. In:宮本昭正,小林節雄,中島重徳編. Outlook for asthma treatment. メディカルトリビューン; 2000.p69-77. |
| 24) |
Leckie MJ, ten Brinke A, Barnes PJ, et al.Effects of IL-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness and the late asthmatic response. Lancet 2000; 356:2144-8. |
| 25) |
Barnes PJ.Therapeutic strategies for allergic diseases. Nature 1999; 402 : B31-8. |
| 26) |
中川武正. アレルゲン免疫療法の過去, 現在, 未来. アレルギー科1998;6:441-8. |
| 27) |
Norman PS, Ohman J Jr, Long A, et al. Treatment of cat allergy with T-cell reactive peptides. Am J Respir Crit Care Med 1996 :154;1623-8. |
| 28) |
Haselden BM, Kay AB, Larche M. IgE-independent MHC-restricted T cell peptide‐induced late asthmatic reaction. J Exp Med 1999;189:1885-94. |
| 29) |
佐藤由紀夫, 粕川禮司. DNAワクチン療法. アレルギー科1998;6:515-20. |
| 30) |
Bertrant CP. Asthma: where beyond steroids? Curr Opin Chem Biol 2000; 4: 407-11. |